Legend Biotech CorpNASDAQ:LEGN
- LAST PRICE47.7900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots47.5000/ 1
- Ask / Lots48.4500/ 1
- Open / Previous Close--- / 47.7900
- Day Range---
- 52 Week Range
- Volume18,099
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LEGN |
|---|---|---|
| 09:32 ET | 6345 | 48.73 |
| 09:34 ET | 100 | 48.69 |
| 09:36 ET | 800 | 48.52 |
| 09:38 ET | 1395 | 48.41 |
| 09:39 ET | 1500 | 48.59 |
| 09:41 ET | 300 | 48.52 |
| 09:43 ET | 600 | 48.35 |
| 09:45 ET | 2400 | 48.64 |
| 09:48 ET | 500 | 48.855 |
| 09:50 ET | 600 | 48.85 |
| 09:52 ET | 700 | 48.865 |
| 09:54 ET | 5424 | 48.43 |
| 09:56 ET | 1576 | 48.73 |
| 09:57 ET | 3723 | 48.81 |
| 09:59 ET | 1130 | 48.795 |
| 10:01 ET | 200 | 48.65 |
| 10:03 ET | 200 | 48.81 |
| 10:06 ET | 1600 | 48.34 |
| 10:08 ET | 700 | 48.13 |
| 10:10 ET | 2865 | 47.975 |
| 10:12 ET | 400 | 47.83 |
| 10:14 ET | 900 | 47.54 |
| 10:15 ET | 435 | 47.46 |
| 10:17 ET | 3927 | 47.5 |
| 10:19 ET | 9100 | 47.33 |
| 10:21 ET | 2497 | 47.435 |
| 10:24 ET | 600 | 47.3 |
| 10:26 ET | 1095 | 47.16 |
| 10:28 ET | 757 | 47.08 |
| 10:30 ET | 900 | 47.235 |
| 10:32 ET | 1000 | 47.23 |
| 10:33 ET | 100 | 47.235 |
| 10:35 ET | 772 | 47.265 |
| 10:37 ET | 1480 | 47.15 |
| 10:39 ET | 200 | 47.15 |
| 10:42 ET | 2047 | 46.97 |
| 10:44 ET | 672 | 46.865 |
| 10:46 ET | 512 | 46.9 |
| 10:48 ET | 300 | 46.915 |
| 10:50 ET | 1606 | 47.07 |
| 10:51 ET | 1723 | 47.215 |
| 10:53 ET | 210 | 47.25 |
| 10:55 ET | 2600 | 47.32 |
| 10:57 ET | 4797 | 47.31 |
| 11:00 ET | 800 | 47.34 |
| 11:02 ET | 2161 | 47.33 |
| 11:04 ET | 1400 | 47.4 |
| 11:06 ET | 700 | 47.375 |
| 11:08 ET | 700 | 47.255 |
| 11:09 ET | 708 | 47.355 |
| 11:11 ET | 1700 | 47.39 |
| 11:13 ET | 800 | 47.38 |
| 11:15 ET | 602 | 47.38 |
| 11:18 ET | 3900 | 47.395 |
| 11:20 ET | 2200 | 47.4875 |
| 11:22 ET | 6873 | 47.445 |
| 11:24 ET | 1250 | 47.45 |
| 11:26 ET | 1800 | 47.38 |
| 11:27 ET | 840 | 47.5 |
| 11:29 ET | 300 | 47.47 |
| 11:31 ET | 100 | 47.45 |
| 11:33 ET | 700 | 47.575 |
| 11:36 ET | 1950 | 47.495 |
| 11:38 ET | 700 | 47.59 |
| 11:40 ET | 100 | 47.55 |
| 11:42 ET | 100 | 47.54 |
| 11:44 ET | 100 | 47.615 |
| 11:45 ET | 1263 | 47.56 |
| 11:47 ET | 900 | 47.59 |
| 11:49 ET | 100 | 47.56 |
| 11:51 ET | 100 | 47.55 |
| 11:56 ET | 1400 | 47.51 |
| 11:58 ET | 200 | 47.54 |
| 12:00 ET | 100 | 47.52 |
| 12:02 ET | 800 | 47.565 |
| 12:03 ET | 3997 | 47.495 |
| 12:05 ET | 400 | 47.49 |
| 12:07 ET | 2261 | 47.51 |
| 12:09 ET | 3151 | 47.51 |
| 12:12 ET | 4085 | 47.445 |
| 12:14 ET | 2708 | 47.5 |
| 12:16 ET | 2098 | 47.575 |
| 12:20 ET | 100 | 47.64 |
| 12:21 ET | 1000 | 47.51 |
| 12:23 ET | 200 | 47.52 |
| 12:25 ET | 300 | 47.575 |
| 12:30 ET | 600 | 47.5 |
| 12:32 ET | 889 | 47.5 |
| 12:34 ET | 100 | 47.51 |
| 12:36 ET | 300 | 47.48 |
| 12:38 ET | 700 | 47.51 |
| 12:39 ET | 300 | 47.52 |
| 12:41 ET | 200 | 47.5 |
| 12:43 ET | 200 | 47.53 |
| 12:45 ET | 2144 | 47.485 |
| 12:48 ET | 600 | 47.5 |
| 12:50 ET | 200 | 47.5 |
| 12:52 ET | 1100 | 47.52 |
| 12:56 ET | 1088 | 47.51 |
| 12:57 ET | 150 | 47.53 |
| 01:01 ET | 850 | 47.51 |
| 01:03 ET | 1200 | 47.5 |
| 01:06 ET | 8321 | 47.43 |
| 01:08 ET | 1063 | 47.53 |
| 01:10 ET | 100 | 47.52 |
| 01:12 ET | 8071 | 47.44 |
| 01:14 ET | 1950 | 47.575 |
| 01:15 ET | 300 | 47.58 |
| 01:17 ET | 1730 | 47.61 |
| 01:19 ET | 490 | 47.59 |
| 01:21 ET | 200 | 47.635 |
| 01:24 ET | 1000 | 47.76 |
| 01:26 ET | 100 | 47.67 |
| 01:28 ET | 100 | 47.67 |
| 01:30 ET | 3623 | 47.625 |
| 01:32 ET | 1100 | 47.63 |
| 01:33 ET | 712 | 47.645 |
| 01:35 ET | 930 | 47.75 |
| 01:37 ET | 300 | 47.8 |
| 01:39 ET | 400 | 47.81 |
| 01:42 ET | 1900 | 47.91 |
| 01:44 ET | 1317 | 47.96 |
| 01:46 ET | 500 | 47.95 |
| 01:48 ET | 703 | 47.99 |
| 01:50 ET | 1721 | 47.9025 |
| 01:51 ET | 500 | 47.88 |
| 01:53 ET | 500 | 47.98 |
| 01:55 ET | 700 | 47.91 |
| 01:57 ET | 1172 | 48 |
| 02:00 ET | 814 | 47.96 |
| 02:02 ET | 1300 | 47.84 |
| 02:04 ET | 1012 | 47.95 |
| 02:06 ET | 600 | 47.9 |
| 02:08 ET | 300 | 47.86 |
| 02:09 ET | 200 | 47.78 |
| 02:11 ET | 600 | 47.59 |
| 02:13 ET | 700 | 47.585 |
| 02:15 ET | 200 | 47.54 |
| 02:18 ET | 100 | 47.63 |
| 02:22 ET | 200 | 47.54 |
| 02:24 ET | 958 | 47.52 |
| 02:26 ET | 100 | 47.51 |
| 02:27 ET | 836 | 47.5 |
| 02:31 ET | 400 | 47.49 |
| 02:33 ET | 1136 | 47.47 |
| 02:36 ET | 300 | 47.52 |
| 02:38 ET | 300 | 47.49 |
| 02:40 ET | 448 | 47.5 |
| 02:42 ET | 462 | 47.5 |
| 02:44 ET | 1800 | 47.5 |
| 02:45 ET | 250 | 47.495 |
| 02:47 ET | 3404 | 47.5 |
| 02:49 ET | 200 | 47.495 |
| 02:51 ET | 6600 | 47.57 |
| 02:54 ET | 400 | 47.57 |
| 02:56 ET | 572 | 47.51 |
| 02:58 ET | 300 | 47.51 |
| 03:00 ET | 100 | 47.48 |
| 03:02 ET | 600 | 47.5 |
| 03:03 ET | 1710 | 47.59 |
| 03:05 ET | 300 | 47.635 |
| 03:07 ET | 2554 | 47.57 |
| 03:09 ET | 938 | 47.59 |
| 03:12 ET | 413 | 47.645 |
| 03:14 ET | 100 | 47.645 |
| 03:16 ET | 636 | 47.58 |
| 03:18 ET | 100 | 47.54 |
| 03:20 ET | 100 | 47.57 |
| 03:21 ET | 2114 | 47.745 |
| 03:23 ET | 1410 | 47.58 |
| 03:27 ET | 790 | 47.47 |
| 03:30 ET | 453 | 47.47 |
| 03:32 ET | 526 | 47.5 |
| 03:34 ET | 1331 | 47.52 |
| 03:36 ET | 1100 | 47.56 |
| 03:38 ET | 400 | 47.53 |
| 03:39 ET | 603 | 47.565 |
| 03:41 ET | 600 | 47.55 |
| 03:43 ET | 2504 | 47.59 |
| 03:45 ET | 1603 | 47.56 |
| 03:48 ET | 804 | 47.55 |
| 03:50 ET | 1100 | 47.555 |
| 03:52 ET | 2983 | 47.57 |
| 03:54 ET | 2835 | 47.62 |
| 03:56 ET | 2273 | 47.6575 |
| 03:57 ET | 8844 | 47.705 |
| 03:59 ET | 96865 | 47.79 |
Today
Yesterday
Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia, from 7:30AM ET on Thursday Oct 03, 2024 by Dow Jones
7:30AM ET on Thursday Oct 03, 2024 by Dow Jones
Sep 30, 2024
DJ Legend Biotech Price Target Maintained With a $73.00/Share by HC Wainwright & Co., from 6:47AM ET on Monday Sep 30, 2024 by Dow Jones
6:47AM ET on Monday Sep 30, 2024 by Dow Jones
Sep 27, 2024
CARVYKTI(R) is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line, from 4:35PM ET on Friday Sep 27, 2024 by Dow Jones
4:35PM ET on Friday Sep 27, 2024 by Dow JonesDJ Legend Biotech Price Target Maintained With a $86.00/Share by RBC Capital, from 9:37AM ET on Friday Sep 27, 2024 by Dow Jones
9:37AM ET on Friday Sep 27, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Legend Biotech Corp | 8.8B | -30.5x | --- |
Ascendis Pharma A/S | 8.5B | -14.8x | --- |
Intra-Cellular Therapies Inc | 7.6B | -83.7x | --- |
Tempus AI Inc | 7.6B | -6.0x | --- |
Revolution Medicines Inc | 7.7B | -12.7x | --- |
Blueprint Medicines Corp | 5.6B | -25.7x | --- |
Company Information
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Contact Information
- Headquarters
- 2101 Cottontail LaneSOMERSET, NJ, United States 08873
- Phone
- 732-317-5050
- Fax
- ---
Executives
- Chairman of the Board
- Fangliang Zhang
- Chief Executive Officer, Director
- Ying Huang
- Chief Financial Officer
- Lori Macomber
- Director
- Ye Wang
- Director
- Li Zhu
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.8B |
|---|---|
Revenue (TTM) | $456.0M |
Shares Outstanding | 184.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.10 |
EPS | $-1.57 |
Book Value | $6.88 |
P/E Ratio | -30.5x |
Price/Sales (TTM) | 19.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -81.89% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
